Amgen's Repatha lowers heart attack, stroke risk – MarketWatch


Investopedia
Amgen’s Repatha lowers heart attack, stroke risk
MarketWatch
Researchers found that Amgen Inc.’s new cholesterol-lowering drug Repatha reduced the risk of deaths, heart attacks and strokes by 20% compared with standard treatment with statin drugs, a benefit that the biotech hopes will persuade health insurers to …
Amgen’s Repatha Cut Stroke, Heart Attack Risk (AMGN)Investopedia
Amgen cholesterol drug cuts heart attack, ...
Seguir leyendo →
0
Página 2.017 de 2.200 «...1.9902.0002.0102.0152.0162.0172.0182.019...»